Grantham, Mayo, Van Otterloo & Co (GMO)
ZBH icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Zimmer Biomet ZBH Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-23,564
Closed -$2.64M – 595
2023
Q3 		$2.64M Buy
23,564
+9,096
+63% +$1.16M 0.01% 382
2023
Q2 		$2.11M Sell
14,468
-3,432
-19% -$466K 0.01% 436
2023
Q1 		$2.31M Sell
17,900
-17,800
-50% -$2.23M 0.01% 407
2022
Q4 		$4.55M Buy
+35,700
New +$4.14M 0.02% 352
2021
Q2 		– Sell
-4,569
Closed -$710K – 866
2021
Q1 		$710K Buy
+4,569
New +$708K ﹤0.01% 642
2017
Q4 		– Sell
-660,729
Closed -$75.1M – 640
2017
Q3 		$75.1M Sell
660,729
-40,633
-6% -$4.69M 0.44% 53
2017
Q2 		$87.4M Buy
701,362
+16,852
+2% +$2M 0.48% 52
2017
Q1 		$81.2M Sell
684,510
-18,134
-3% -$2.06M 0.46% 55
2016
Q4 		$70.4M Buy
702,644
+142,807
+26% +$15.3M 0.38% 69
2016
Q3 		$70.7M Buy
559,837
+7,107
+1% +$878K 0.33% 74
2016
Q2 		$64.6M Buy
552,730
+65,297
+13% +$7.39M 0.27% 86
2016
Q1 		$50.5M Sell
487,433
-115,338
-19% -$11.2M 0.19% 116
2015
Q4 		$60M Sell
602,771
-75,546
-11% -$7.39M 0.22% 89
2015
Q3 		$61.9M Sell
678,317
-214,748
-24% -$21.5M 0.21% 93
2015
Q2 		$94.7M Sell
893,065
-108,768
-11% -$12M 0.31% 71
2015
Q1 		$114M Buy
1,001,833
+6,013
+0.6% +$686K 0.34% 58
2014
Q4 		$110M Sell
995,820
-155,610
-14% -$16.4M 0.3% 63
2014
Q3 		$112M Buy
1,151,430
+65,095
+6% +$6.4M 0.3% 60
2014
Q2 		$110M Sell
1,086,335
-698,442
-39% -$68.1M 0.3% 61
2014
Q1 		$164M Sell
1,784,777
-571,778
-24% -$52.7M 0.43% 47
2013
Q4 		$213M Sell
2,356,555
-258,861
-10% -$22.4M 0.52% 38
2013
Q3 		$209M Sell
2,615,416
-778,527
-23% -$61.3M 0.55% 33
2013
Q2 		$247M Buy
+3,393,943
New +$254M 0.64% 34

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ZBH Position: Q4 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 23,564 shares — an estimated $2.64M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ZBH in Q2 2013 and held it in 23 quarters. The position peaked at $247M in Q2 2013. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 23,564 Zimmer Biomet shares in Q4 2023, an estimated $2.64M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Zimmer Biomet in Q2 2013 and held it in 23 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Zimmer Biomet position peaked at $247M in Q2 2013.
  • 1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2023, filed 13 Feb 2024.